• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

极为罕见的病例:一例BAP1突变的原发性腹膜间皮瘤

The Rarest of the Rare: A Case of BAP1-Mutated Primary Peritoneal Mesothelioma.

作者信息

Gupta Aanchal, Vasileva Alisa, Manthri Sukesh

机构信息

Internal Medicine, St. Martinus University Faculty of Medicine, Willemstad, CUW.

Research, Ballad Health, Johnson City, USA.

出版信息

Cureus. 2021 Sep 29;13(9):e18380. doi: 10.7759/cureus.18380. eCollection 2021 Sep.

DOI:10.7759/cureus.18380
PMID:34725624
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8555483/
Abstract

Malignant mesotheliomas (MM), as described are rare tumors that are mostly associated with occupational exposure to asbestos. They most commonly occur in the pleura. Other unfamiliar sites where they can occur are the peritoneum, pericardium, and tunica vaginalis. There is no significant correlation between the amount and duration of asbestos exposure to mesothelioma development as reported by various studies over the years. Apart from the environmental exposure, the development of malignant mesothelioma has been linked to a mutation in the BAP1 gene, which can predispose the patient to develop other malignancies associated with BAP1 mutation. We report a case of a 43-year-old man without any significant risk factors, who presented with a complaint of abdominal discomfort and was found to have malignant peritoneal mesothelioma (MPM). With a known familial history of mesothelioma and melanoma, our patient underwent genetic testing which revealed a mutation in BAP1, affirming the strong association with the development of MPM. Young patients who develop malignant mesothelioma without risk factors for MM should have germline testing for BAP1. This case report is unique and highlights a familial variant of mesothelioma, even rare with peritoneal mesothelioma in our patient.

摘要

如前所述,恶性间皮瘤(MM)是罕见肿瘤,大多与职业性接触石棉有关。它们最常发生于胸膜。其他不常见的发病部位包括腹膜、心包和鞘膜。多年来的各种研究报告显示,石棉接触量和接触时长与间皮瘤的发生之间并无显著关联。除环境暴露外,恶性间皮瘤的发生还与BAP1基因突变有关,该突变会使患者易患其他与BAP1突变相关的恶性肿瘤。我们报告一例43岁男性病例,该患者无任何显著风险因素,因腹部不适就诊,被诊断为恶性腹膜间皮瘤(MPM)。鉴于患者有间皮瘤和黑色素瘤家族史,我们对其进行了基因检测,结果显示BAP1基因突变,证实了该突变与MPM发生之间的紧密关联。无MM风险因素却发生恶性间皮瘤的年轻患者应进行BAP1种系检测。本病例报告具有独特性,凸显了间皮瘤的一种家族性变体,在我们的患者中,即使是腹膜间皮瘤也很罕见。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83a7/8555483/fbe724a345cb/cureus-0013-00000018380-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83a7/8555483/08c56f29e0f4/cureus-0013-00000018380-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83a7/8555483/fbe724a345cb/cureus-0013-00000018380-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83a7/8555483/08c56f29e0f4/cureus-0013-00000018380-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83a7/8555483/fbe724a345cb/cureus-0013-00000018380-i02.jpg

相似文献

1
The Rarest of the Rare: A Case of BAP1-Mutated Primary Peritoneal Mesothelioma.极为罕见的病例:一例BAP1突变的原发性腹膜间皮瘤
Cureus. 2021 Sep 29;13(9):e18380. doi: 10.7759/cureus.18380. eCollection 2021 Sep.
2
Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes.间皮瘤患者对石棉的敏感性增加,并且存在 BAP1 或其他 DNA 修复基因中的致病性种系变异。
Genes Chromosomes Cancer. 2018 Nov;57(11):573-583. doi: 10.1002/gcc.22670.
3
BAP1 protein is a progression factor in malignant pleural mesothelioma.BAP1 蛋白是恶性胸膜间皮瘤的进展因子。
Pathol Oncol Res. 2014 Jan;20(1):145-51. doi: 10.1007/s12253-013-9677-2. Epub 2013 Aug 22.
4
Germline BAP1 mutations predispose to malignant mesothelioma.胚系 BAP1 突变易患恶性间皮瘤。
Nat Genet. 2011 Aug 28;43(10):1022-5. doi: 10.1038/ng.912.
5
Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.Bap1的种系突变加速石棉诱导的恶性间皮瘤的发展。
Cancer Res. 2014 Aug 15;74(16):4388-97. doi: 10.1158/0008-5472.CAN-14-1328. Epub 2014 Jun 13.
6
Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer.有癌症家族史的石棉暴露恶性间皮瘤患者的种系BAP1突变图谱
Cancer Res. 2016 Jan 15;76(2):206-15. doi: 10.1158/0008-5472.CAN-15-0295. Epub 2015 Dec 30.
7
Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation.分化良好型乳头状间皮瘤:葡萄牙一家系中存在胚系 BAP1 突变的聚集性发病。
Ann Oncol. 2013 Aug;24(8):2147-50. doi: 10.1093/annonc/mdt135. Epub 2013 Apr 12.
8
Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.通过对高危地区家族性和散发性间皮瘤的分析推断种系BAP1突变与石棉暴露情况
Genes Chromosomes Cancer. 2015 Jan;54(1):51-62. doi: 10.1002/gcc.22218. Epub 2014 Sep 18.
9
Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma.种系BAP1杂合小鼠中最小石棉暴露与炎症反应失调和间皮瘤风险增加有关。
Oncogene. 2016 Apr 14;35(15):1996-2002. doi: 10.1038/onc.2015.243. Epub 2015 Jun 29.
10
BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma.BAP1突变是腹膜恶性间皮瘤中常见的体细胞事件。
J Transl Med. 2015 Apr 16;13:122. doi: 10.1186/s12967-015-0485-1.

本文引用的文献

1
Efficacy of nivolumab and ipilimumab in patients with malignant pleural mesothelioma is related to a subtype of effector memory cytotoxic T cells: Translational evidence from two clinical trials.纳武利尤单抗和伊匹单抗治疗恶性胸膜间皮瘤的疗效与效应记忆细胞毒性 T 细胞亚群有关:来自两项临床试验的转化证据。
EBioMedicine. 2020 Dec;62:103040. doi: 10.1016/j.ebiom.2020.103040. Epub 2020 Nov 7.
2
Mesothelioma developing in carriers of inherited genetic mutations.在携带遗传性基因突变的个体中发生的间皮瘤。
Transl Lung Cancer Res. 2020 Feb;9(Suppl 1):S67-S76. doi: 10.21037/tlcr.2019.11.15.
3
Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial.
尼伏鲁单抗或尼伏鲁单抗联合伊匹单抗治疗复发恶性胸膜间皮瘤(IFCT-1501 MAPS2):一项多中心、开放标签、随机、非对照、2 期临床试验。
Lancet Oncol. 2019 Feb;20(2):239-253. doi: 10.1016/S1470-2045(18)30765-4. Epub 2019 Jan 16.
4
Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial.伊匹单抗和纳武利尤单抗治疗复发性恶性胸膜间皮瘤(INITIATE):一项前瞻性、单臂、2 期临床试验的结果。
Lancet Respir Med. 2019 Mar;7(3):260-270. doi: 10.1016/S2213-2600(18)30420-X. Epub 2019 Jan 16.
5
Malignant peritoneal mesothelioma: a review.恶性腹膜间皮瘤:综述
Transl Lung Cancer Res. 2018 Oct;7(5):537-542. doi: 10.21037/tlcr.2018.10.04.
6
Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members.检测腹膜间皮瘤患者胚系 BAP1 突变:对患者及其家庭成员的获益。
J Transl Med. 2018 Jul 13;16(1):194. doi: 10.1186/s12967-018-1559-7.
7
, a tumor suppressor gene driving malignant mesothelioma.一种驱动恶性间皮瘤的肿瘤抑制基因。 (你提供的原文似乎不完整,前面应该还有相关内容,仅这一句翻译出来是这样的意思 )
Transl Lung Cancer Res. 2017 Jun;6(3):270-278. doi: 10.21037/tlcr.2017.05.03.
8
Mesothelioma: recent highlights.间皮瘤:近期要点
Ann Transl Med. 2017 Jun;5(11):238. doi: 10.21037/atm.2017.04.29.
9
Malignant peritoneal mesothelioma: a review.恶性腹膜间皮瘤:综述
Ann Transl Med. 2017 Jun;5(11):236. doi: 10.21037/atm.2017.03.96.
10
Patterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972-2009.1972 - 2009年新南威尔士州恶性胸膜和腹膜间皮瘤的发病率、死亡率及生存率模式
Aust N Z J Public Health. 2016 Jun;40(3):255-62. doi: 10.1111/1753-6405.12503. Epub 2015 Dec 29.